Litcius/Paper detail

Andrographolide stabilized-silver nanoparticles overcome ceftazidime-resistant Burkholderia pseudomallei: study of antimicrobial activity and mode of action

Saengrawee Thammawithan, Chanon Talodthaisong, Oranee Srichaiyapol, Rina Patramanon, James A. Hutchison, Sirinan Kulchat

2022Scientific Reports22 citationsDOIOpen Access PDF

Abstract

Abstract Burkholderia pseudomallei ( B. pseudomallei ) is a Gram-negative pathogen that causes melioidosis, a deadly but neglected tropical disease. B. pseudomallei is intrinsically resistant to a growing list of antibiotics, and alternative antimicrobial agents are being sought with urgency. In this study, we synthesize andrographolide-stabilized silver nanoparticles (andro-AgNPs, spherically shaped with 16 nm average diameter) that show excellent antimicrobial activity against B. pseudomallei , including ceftazidime-resistant strains, being 1–3 orders of magnitude more effective than ceftazidime and 1–2 orders of magnitude more effective than other green-synthesized AgNPs. The andro-AgNPs are meanwhile non-toxic to mammalian cell lines. The mode of action of Andro-AgNPs toward B. pseudomallei is unraveled by killing kinetics, membrane neutralization, silver ions (Ag + ) release, reactive oxygen species (ROS) induction, membrane integrity, and cell morphology change studies. The antimicrobial activity and mode of action of andro-AgNPs against B. pseudomallei reported here may pave the way to alternative treatments for melioidosis.

Topics & Concepts

Burkholderia pseudomalleiCeftazidimeAndrographolideAntimicrobialMode of actionMicrobiologyMelioidosisChemistryBiologyBacteriaPharmacologyBiochemistryPseudomonas aeruginosaGeneticsBurkholderia infections and melioidosisNanofluid Flow and Heat TransferMoringa oleifera research and applications
Andrographolide stabilized-silver nanoparticles overcome ceftazidime-resistant Burkholderia pseudomallei: study of antimicrobial activity and mode of action | Litcius